Granted Patent B2

US 12,458,484 · App. 17/341,038 · Granted Nov 4, 2025

Inventors: John Hall (North Salt Lake, UT); Wayne Mower (Bountiful, UT); Rachel Simmons (North Salt Lake, UT); Bart Dolmatch (Palo Alto, CA)

Assignee: Merit Medical Systems, Inc.

A61F2/07A61F2/915A61F2/945A61L27/18A61L27/507A61L31/06B32B27/08B32B27/322C08L27/18A61F2002/072A61F2210/0014A61F2210/0076A61F2220/005A61F2240/001A61F2250/0018A61F2250/0023A61F2250/0028A61F2250/0051A61F2250/0067A61F2250/0069B32B2307/7265B32B2535/00

Abstract

Claims (30)

1 . A covered stent, comprising:

a scaffolding structure comprising a midsection and an end section; and

a cover coupled to the scaffolding structure, comprising a multi-layer construct comprising:

an inner layer of rotational spun polytetrafluoroethylene (PTFE) comprising a plurality of pores;

an outer layer of expanded PTFE comprising a plurality of pores with an average internodal distance less than 80 microns; and

a tie layer disposed between the inner layer and the outer layer,

wherein the scaffolding structure is disposed between the inner layer and the outer layer, and

wherein each layer of PTFE in the multi-layer construct comprises pores larger than 8 microns, wherein the multi-layer construct comprises a tortuous path through the pores from an inner surface to an outer surface of the multi-layer construct, and wherein the multi-layer construct is configured to be impermeable to red blood cell migration across the multi-layer construct.

2 . The covered stent of claim 1 , wherein the inner layer is configured to allow less than 0.1% of red blood cells that contact the inner layer under biological pressure to migrate across the inner layer.

3 . The covered stent of claim 1 , wherein the multi-layer construct is configured to allow less than 0.1% of red blood cells that contact the multi-layer construct under biological pressure to migrate across the multi-layer construct.

4 . The covered stent of claim 1 , wherein at least one of the layers of the multi-layer construct is nonporous.

5 . The covered stent of claim 4 , wherein the multi-layer construct is configured to allow less than 0.1% of red blood cells that contact the multi-layer construct under biological pressure to migrate across the multi-layer construct.

6 . A covered stent, comprising:

a scaffolding structure comprising a midsection and an end section,

wherein a resistance to radial compression of the midsection is greater than a resistance to radial compression of the end section; and

a cover coupled to the scaffolding structure, comprising:

an inner layer of rotational spun polytetrafluoroethylene (PTFE) comprising a plurality of pores;

an outer layer of expanded PTFE comprising a plurality of pores with an average internodal distance less than 80 microns; and

a tie layer disposed between the inner layer and the outer layer,

wherein the scaffolding structure is disposed between the inner layer and the outer layer, and

wherein each layer of PTFE in the multi-layer construct comprises pores larger than 8 microns, wherein the cover comprises a tortuous path through the pores from an inner surface to an outer surface of the cover, and wherein the cover is configured to be impermeable to red blood cell migration across the cover.

7 . The covered stent of claim 6 , wherein the end section comprises a circumferential edge.

8 . The covered stent of claim 7 , wherein the resistance to radial compression of the end section is configured to reduce aggravation of tissue at the circumferential edge.

9 . The covered stent of claim 7 , wherein the resistance to radial compression of the end section is configured to reduce an occurrence of stenosis of the covered stent at the circumferential edge.

10 . The covered stent of claim 6 , wherein the resistance to radial compression of the end section is configured to promote endothelial cell growth on an inner surface of the inner layer.

11 . The covered stent of claim 6 , wherein the resistance to radial compression of the midsection is configured to match a compliance of a vessel wall in contact with the midsection.

12 . The covered stent of claim 6 , wherein the resistance to radial compression of the end section is configured to match a compliance of a vessel wall in contact with the end section.

13 . The covered stent of claim 6 , wherein the scaffolding structure is configured to exert an outward radial force on a vessel wall.

14 . The covered stent of claim 13 , wherein the outward radial force is configured to one or more of keep a vessel lumen open, prevent restenosis of the vessel lumen, and inhibit migration of the covered stent within the vessel lumen.

15 . The covered stent of claim 13 , wherein the outward radial force ranges from a force configured to promote healing of the vessel wall to a force configured to cause trauma to the vessel wall.

Assignments (2)

Continuity (4)

References Cited (400)